Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Goldman Sachs Group (NY:GS)

690.81 +3.65 (+0.53%)
Official Closing Price Updated: 7:00 PM EDT, Jun 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Goldman Sachs Group

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
99 100 Next >
Here's the Average Stock Market Return in the Past 10 Years, and What Wall Street Expects in the Future
Via The Motley Fool
Airbnb (ABNB) Shares Skyrocket, What You Need To Know
Shares of online accommodations platform Airbnb (NASDAQ:ABNB) jumped 15.9% in the morning session after the company reported strong fourth-quarter results: The top line was strong, with gross booking... 
Via StockStory
Palo Alto Analysts Optimistic On Revenue Growth, Expanding Market Share
Palo Alto Networks Inc (NASDAQ: PANW) shares dropped despite upbeat Q2 results and strong analyst takeaways from Goldman Sachs, Needham, Rosenblatt, and Truist Securities. 
Via Benzinga
Prediction: This Unstoppable Stock Will Soar to $10 Trillion By 2030
An industry-leading position and strong secular tailwinds should help drive this artificial intelligence (AI) pioneer higher. 
Via The Motley Fool
Topics Artificial Intelligence
What's Going On With AMC Shares Wednesday?
AMC stock is trading higher on Wednesday after Goldman Sachs disclosed a sizable stake in the company. 
Via Benzinga
Here's How Much You Would Have Made Owning Goldman Sachs Gr Stock In The Last 5 Years
Via Benzinga
Why Is Rare Disease Focused Ascendis Pharma Stock Trading Higher On Thursday?
Ascendis Pharma beat Q4 earnings and revenue estimates, driven by a $100M Novo Nordisk deal and Yorvipath's EU launch. Goldman Sachs raised its price target. 
Via Benzinga
Bank Brass Expect Trump Deregulatory Agenda To 'Strengthen Customer Activity': Analyst
Trump's tariff policies haven't affected Wall Street banks' optimism towards his pro-business agenda. Deregulation and tax cuts are expected to boost growth. 
Via Benzinga
Topics Government World Trade
Buffett Buys More Occidental Petroleum—Sticking to His Playbook
After a recent episode of volatility in the stock market, there is one clear sign of where opportunities may still lie for investors. 
Via MarketBeat
Topics ETFs
Coca-Cola's Strong Q4 Performance Reinforces Pricing Power, But Analysts Flag Interest Cost Risks
Coca-Cola's Q4 results beat analyst forecasts, driven by impressive +9% YoY price/mix growth. Analysts from Piper Sandler, Goldman Sachs, and BofA Securities shared opinions, highlighting KO's pricing... 
Via Benzinga
Verizon Analyst Sees Improving Trends As Company Sizes Up AI Opportunity
Verizon Communications, Inc. (NYSE:VZ) released earnings for the fourth quarter of fiscal-year 2024 last month. Following the earnings report, Goldman Sachs hosted an investor meeting with key members... 
Via Benzinga
Topics Artificial Intelligence
ROBERTSON STEPHENS APPOINTS ESTA STECHER AS BOARD ADVISOR
Financial Advisory Firm Leverages Stecher’s Banking, Legal, and Investment Knowledge to Strengthen Board and Drive Growth as an Advisor 
Via News Direct
'Investors Seem To Remain Poised For A Good Year In The Markets' Even As Valuation Remains Elevated, Says Fidelity's Macro Chief
Jurrien Timmer, Director of Global Macro at Fidelity Investments, expressed concerns about the strength of the S&P 500's recovery. His insights come amidst a backdrop of soaring valuations and robust... 
Via Benzinga
Topics Stocks
Goldman Sachs Increases Bitcoin ETF Stake Over $1.5 Billion In Q4, Reports A Massive 1793% Jump In Ethereum ETF Holdings
Investment banking giant Goldman Sachs (NYSE:GS) loaded up more shares of Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) spot exchange-trade 
Via Benzinga
Topics ETFs
Regenxbio's Gene Therapy Outlook Dims As Rival Treatments Gain Ground, Goldman Sachs Warns
Regenxbio's gene therapy faces market challenges as Goldman Sachs lowers its rating and price target, citing competition and declining appeal in retinal diseases. 
Via Benzinga
Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty
Goldman Sachs downgraded Dynavax to Sell, citing increased competition in the shingles vaccine market and uncertainty over hepatitis B revaccination demand. 
Via Benzinga
Alibaba Cloud's Growth Accelerates With AI, Analyst Weighs DeepSeek's Rising Competition
Goldman Sachs analyst maintains Buy on Alibaba Group with $117 price target. Notes strong performance in Qwen2.5 model and potential for cloud growth. 
Via Benzinga
Topics Artificial Intelligence
Regulatory Freeze At CFPB: These ETFs Could Gain As Oversight Weakens
A CFPB shut down raises concerns about consumer rights but also presents opportunity for investors in bank and fintech ETFs. 
Via Benzinga
Topics ETFs
Here’s What Goldman CEO Said On Acquisitions In Asset And Wealth Management, Trump Administration’s Growth Agenda
According to a Bloomberg report, David Solomon stated that the market is undervaluing the bank’s trading unit and urged investors to consider a longer-term view of the business. 
Via Stocktwits
Topics Government
Banking Stocks Lead the Week: Stronger Economy on the Horizon?
Recent price action in banking stocks led investors to a couple of conclusions about the United States economy and where the opportunity might be. 
Via MarketBeat
Topics ETFs Economy
Is Goldman Sachs Stock a Buy Now?
Via The Motley Fool
Corporate America's Best Earnings In 3 Years: Will Tariffs End Wall Street's Honeymoon?
Corporate America cheers strong earnings season in 2024, but trade uncertainty looms as Trump's tariff plans dominate earnings calls. 
Via Benzinga
Topics Government World Trade
I'd Still Buy Alphabet Stock Despite the Stumble Over Q4 Cloud Growth. Here's Why.
Too many investors are looking right past a couple of obscured bullish details regarding the company's future. 
Via The Motley Fool
Intuit's AI, Market Expansion Position It For Long-Term Growth: Goldman Sachs
Goldman Sachs analyst Kash Rangan maintains a Buy rating on Intuit Inc (NASDAQ:INTU) with an $800 price target. Despite intensifying competition in the lower tax market, Rangan sees Intuit capturing... 
Via Benzinga
Topics Artificial Intelligence
Former Veep Al Gore Is Renting Out His Suburban DC Home for $9,000/month. Not That He Needs the Money. He's Worth $300M
Via Benzinga
Bank Stocks Rally After Federal Reserve Releases 2025 Stress Test Parameters With Smaller Shocks
According to the new scenario, the U.S. unemployment rate will rise nearly 5.9 percentage points to a peak of 10%. 
Via Stocktwits
Topics Economy
Peter Schiff Slams Fed's Stress Tests For Ignoring Stagflation Risks: 'They Know No Major Bank Could Survive It'
Renowned economist Peter Schiff has expressed criticism of the Federal Reserve's recent bank stress tests, highlighting the lack of preparation for a potential stagflation scenario. 
Via Benzinga
Topics Economy
Fed Eases Bank Stress Tests, Drops Climate Risks: Financial Stocks Hit Record Highs
Fed dials back regulatory burden on major US banks, ending climate stress test and rolling out more favorable 2025 scenario. Relief for Goldman Sachs and Morgan Stanley expected. 
Via Benzinga
Topics Economy
Stocks Edge Higher, Bank Giants Rally, Palantir Skyrockets: What's Driving Markets Thursday?
It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report set for Friday morning. The S&P 500 and the Nasdaq 100 edged... 
Via Benzinga
Topics Stocks
Institutional Investors Continue to Consider ESG Despite the Ongoing Backlash
Via Investor Brand Network
Topics Government
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.